However, information on the CD4+/CD8+ ratio in CCA is limited, although an increase in the CD4+/CD8+ ratio has been associated with an improved prognosis in hepatocellular carcinoma following transarterial chemoembolization (TACE) [17]. Here, CD8A is linked to hepatocellular carcinoma.